Good morning. Semis lead a green premarket — AAOI +14% after the fiber-optic beat, lifting FN and COHR with it. The tape rotates out of memory into NVDA ahead of the 8/26 print, and Citi's MU downgrade fuels that trade: DRAM/NAND peaks, CXMT/YMTC capacity breaks 2H27. ACMR confirms the packaging capex cycle — ECP +168% Y/Y, advanced packaging +153%, revenue $292.9M vs the $269.3M BOGY. VST tells the power story: revenue MISSED ($4.02B vs $4.93B est) but EBITDA BEAT ($1.77B, +31%), with management pricing existing dispatchable gen at replacement cost, not spot. Bullish read-through for CEG, TLN, NRG — bearish for FLNC, as VST admits battery returns collapsed to ~20% of original expectations. Two macro threads frame Asia: Texas' pause on data center connections risks a FIFTH of the US pipeline, and DeepSeek's hedge fund book is DOWN >20% in July. (Both kill speculative AI junk.) Three themes today: memory peaking = rotation into compute; power scarcity = repricing incumbents, not developers; optics = cleanest confirmation AI capex breadth. GOOGL stays the short — Gemini trails the frontier, talent keeps leaving, Search is 60% of profits, and 27x forward leaves no room for disruption. We'll hit up MU, VST, and AAOI first, then get to power and semis.
Cleanest print in the software complex this season. Q2 was a beat-and-raise that actually justified the ~15% aftermarket pop to $224 — not a guide-down disguised as good optics. ORGANIC GROWTH 17% delivered vs 10-11% GUIDANCE; buy-side was whispering 15-16% at best. That's the kind of over-delivery that forces PMs to re-underwrite the whole story.
Adjusted EPS $1.47 vs $1.32 bogey. Revenue $1.5B vs $1.43B consensus. Reported revenue up 22% including U.S. carrier pass-through fees.
The internals are as strong as the headline: ISV >25%, SELF-SERVE >30%, messaging ~18% ex-fees. Both messaging and voice accelerated sequentially — that's CPaaS share gains, not AI-narrative air cover.
Management didn't just beat, they reset the bar. FY26 organic guide RAISED TO 13-13.5% FROM 9.5-10.5% (mid-point 13.25%). And it's profitable growth: EBIT +29% YoY, fifth consecutive quarter of accelerating non-GAAP gross profit, record operating income and FCF. This is operating leverage turning visible.
Four PT raises in one morning — Needham to $280 (from $250), Rosenblatt to $275 (from $230), TD Cowen to $260 (from $245), Stifel to $275 (from $260). Three Buys and one Hold. The interesting tension is Stifel: they admit 17% crushed the guide AND buy-side expectations, then still say Hold. That's not an execution debate anymore — that's a valuation argument, and it's fair game.
TD Cowen frames the durable thesis:
Twilio's positioning at the intersection of AI and B2C engagement, with the Voice opportunity still in early stages and durable growth vectors across the rest of the business.
Needham is more aggressive — CPaaS position "unmatched" and the 13.25% organic mid-point is conservative with AI still in early innings for customer support and B2B sales. New PTs imply roughly 30x EV/CY27E FCF.
Bull: 17% organic translating to 29% EBIT growth is the math that used to be a promise. Messaging AND voice both accelerating means the share-gain story is real, and AI-driven customer engagement is the next S-curve. If Needham's right that the guide is conservative, this is a compounder still trading below its growth-adjusted multiple.
Bear: Name a price. Six months in, stock is +68%; the easy money was made. Stifel's Hold at $275 says the multiple is now the debate — ~30x forward FCF for a company that just de-risked, not re-accelerated. Street low PT is $120; the dispersion of conviction is wide, and if organic settles at 13.25% mid-point, the multiple compresses.
Net/net: A+ quarter, no way around it. Own it into strength, but the next leg isn't about the print — it's whether the AI agent thesis shows up in calendar 2027 bookings, not customer support pilots. Watch the February guide. That's the tell.
This is not a macro tape problem. This is a share-loss problem. TTD guided to its FIRST NON-PANDEMIC YoY REVENUE DECLINE in Q3 — revenue at least $650M, down 12% YoY and ~19% below Street. The stock already knows: down 80% over the past year, $17.67, sitting on the $16.70 52-week low. The narrative has flipped from "the inevitable CTV winner" to "the expensive DSP getting squeezed by cheaper pipes."
Q2 revenue $715M, +3% YoY — missed by 5%. EBITDA $241M, 34% margin, down ~5pts YoY and 9% below consensus. The guide is the real story: Q3 EBITDA ~$160M, 25% margin, down 18pts YoY and MORE THAN 50% BELOW CONSENSUS. That's not a pause. That's a cliff.
Management's culprit: CPG and autos, 25% of revenue. The deeper tell — clients didn't just cut. They defected.
"Clients either pulled back budgets significantly or chose programmatic guaranteed offerings from lower-priced competitors."
That's the whole thesis in one line. Not a delayed recovery. A structural share shift to cheaper alternatives. And the strategic response confirms it: UBS notes TTD has adopted a "more conciliatory approach to take rates." The company that never discounts is now discounting. That tells you everything about competitive intensity.
18 analysts revised estimates down. The downgrade wave was broad and brutal:
Bear case: The "macro" excuse doesn't hold up. Magnite, PubMatic, Publicis, Meta, and Amazon Ads ALL reported strong ad trends in Q2. The ad market is fine. TTD is losing. When CPG and auto budgets are walking to cheaper programmatic guaranteed offerings, that's competitive share loss dressed up as cyclical weakness. First revenue decline ex-pandemic means the growth algorithm is broken.
Bull case: UBS's Stephen Ju keeps the Buy — joint business plans signed +38% YoY, and spend from those contracts growing SIX TIMES FASTER than total. If new contracts compound, ~$1B of recaptured spend offsets the shortfall. Stock trades ~5x 2027E EV/EBITDA. Path: restructuring hits 2026, budget recapture into 2027, and you're buying the recovery at trough multiples. UBS also flags a "GREAT" financial health score — balance sheet isn't the issue here. Demand is.
The problem for bulls: every recovery story starts with "the data will inflect." TTD just guided down 19% below Street for Q3. The next quarter is already a write-off. 2027 is a hope. At $8.3B market cap, the stock is pricing a successful turnaround, but there's zero reported evidence the defection to cheaper alternatives has stopped. I'd wait for JBP spend to show up in actual revenue before catching this knife.
Same print, two very different conclusions. Needham presses the gas — Buy, PT to $115 from $80 (a 44% hike). Morgan Stanley stays parked — Equalweight, PT to $100 from $95. Both saw the same cloud acceleration, the same security attach story, the same stock up 114% in a year. They just disagree on what's still on the table.
CLOUD REVENUE $87.5M, +53% YOY — beat investor expectations. Management guided 41-43% cloud growth for 2026. Gross margins 78%. EPS $0.27 vs $0.24 expected. Revenue $163.8M vs $155.49M. Raised full-year guidance. Stock popped post-print.
The detail that matters: overage levels from Q1 held into Q2. Customers over-consumed against their contracts in Q1, and usage didn't fall back. Could be durable demand. Could be customers bad at forecasting. The market's paying for the first read.
Bull (Needham): security attach is the pricing lever. 80% OF THE $1M ARR COHORT ADDED SECURITY this quarter. 40% of new logos landed with security attached. Management says security is lifting ASPs and the pipeline is growing. Usage-driven cloud plus security-driven pricing — that's a nice compounding story, especially with NDR at 121%.
Bear (Morgan Stanley): the re-rating already happened — 100%+ since March. At 15x CY27 sales, the stock prices in the bull case. MS's issue: they need overage to convert cleanly into committed contracts over consecutive quarters. The bear case — overage normalizes as customers get better at forecasting usage — cannot yet be disproven from the print or the implied 2H outlook.
"We would need to see overage explicitly flowing into raised commitments over consecutive quarters or a pullback in shares before becoming more constructive on the stock."
That's the line between $115 and $100. Needham doesn't need that proof — the security attach data is enough. But with the stock up 114% over one year and 73% in six months, the easy money's in the rearview. FROG's a good company. The question is whether the market's already paid for it.
Cloud re-accelerated for a second straight quarter and the CEO put $250M of his own money behind the stock. Bears lost the quarter — the +30% after-hours move says the short side was crowded and caught flat-footed. The real debate is the guide: 18% FY27 subscription ARR growth is a major step-down from cloud's 30.8% print. This is a re-rating trade colliding with a decel guide. Respect both.
Clean beat across the board. Adjusted EPS $1.87 vs $1.50 consensus, revenue $1.77B vs $1.66B. GM 84.8% (yes, that's a software business). Buy-side expectations had turned negative into the print — TD Cowen said it explicitly — and they got run over.
THE HEADLINE: cloud growth accelerated 220bps TO 30.8%, following the 200bps acceleration in Q3. Back-to-back. That's an inflection, not a blip. Jefferies flags cloud revenue beating guidance by 5 FULL POINTS. BTIG and Jefferies both went to Buy with PTs at $180 and $200 respectively.
Management introduced a new metric: first-time FY27 subscription ARR growth guide of 18%, disclosed quarterly. Discipline. But it implies real decel — Q1 cloud guide of 28.5% is a 230bps step-down. The acceleration plateaus. Don't ignore that.
Bull: Cloud re-accel + enterprise strength + no AI disruption (TD Cowen's words, not mine) + CEO 10b5-1 for $250M. Mike Cannon-Brookes doesn't set up a structured purchase plan to watch the stock fade. And the comp mix shift toward cash vs SBC directly attacks the dilution overhang that has always capped TEAM. The bulls have the momentum and the print.
Bear: TD Cowen holds at $145 — roughly 19x EV/CY27 FCF — pointing at FY27 growth AND margin compression, ongoing data center-to-cloud transition drag, and decelerating ARR. Kicker: no measurable AI revenue contribution. The AI narrative is still narrative. When expectations are negative and you pop 30%, a lot of that is positioning, not fundamentals.
"Growth exceeded buy-side expectations, which had been negative heading into the results." — TD Cowen
The 18% ARR guide is the new bogey. Management handcuffed themselves to that number with a fresh quarterly disclosure cadence. If cloud holds 28.5% and ARR guides up from here, the re-rating continues. If they're back to decel by Q2, TD Cowen's $145 starts looking like the more honest number.
The CEO's $250M is the tell. I lean with him — but I'm respecting the guide.
VERDICT: THE FOX MERGER TURNED ROKU INTO AN ARB, NOT A GROWTH STOCK. FIVE FIRMS DOWNGRADED TO NEUTRAL/HOLD IN THE LAST 24 HOURS — ALL TO $155-160, ALL ON DEAL MATH, NOT FUNDAMENTALS. AND THE KICKER? Q2 WAS ACTUALLY A MONSTER BEAT.
Revenue $1.355B, +21.9% YoY, ~5% ABOVE COMPANY GUIDANCE. Platform revenue and subscriptions BOTH +25% YoY — the two-sided monetization story is intact. Adjusted EBITDA $254M, +225%, 46% above Seaport's estimate. Haircut that: ~$38M is a one-time tariff refund benefit. Still clean even after stripping it. FCF $243M, more than doubled YoY, and TTM FCF >$700M — A RECORD. Installed base >100M homes. Guidance suspended because of the deal, because of course it is.
Needham holds the only Buy above the deal price ($170) and makes a genuinely differentiated point: as memory prices rise, Roku TVs are taking shelf space from Android and Fire TVs. (Component cost pressure hits the higher-spec competitors harder.) That's a share-shift narrative that works WITH the macro, not against it.
Fox is paying $20B in cash and stock at $160. Netflix reportedly tried to buy Roku first and lost — that tells you the asset had multiple bidders and the price got pushed for a reason. What follows is a downgrade conveyor belt: Wedbush (Neutral, $155, off Best Ideas), JPMorgan (Neutral, $160), Loop (Hold, $155), Jefferies (Hold, $160), Seaport (Neutral, $155). All deal-driven. The stock trades ~4% below deal value. Seaport frames it cleanly:
"The gap reflects the arbitrage cost to carry the transaction. Longer-term value will presumably accrue to Fox shareholders but will require time to close and integrate."
Bear: this is a fixed-income trade with streaming risk. You're clipping a 4% spread until close, and any regulatory hiccup is pure downside. The 81% run over the past year is realized; the growth belongs to Fox shareholders now.
Bull: Roku is the platform asset a giant had to buy rather than build. Record FCF, 100M+ homes, proprietary first-party viewing data, and Fox's ad-sales muscle (Wolfe thinks Fox doubles long-term sales growth with this). At $160, you're getting a scaled CTV OS at effectively the cash offer. Needham's $170 is the only number that looks through the deal to the merged value.
Long ROKU today = long carry on a Fox spread, not long the thesis. If you want the streaming compounder, the expression is Fox, not Roku. The downgrade parade isn't a fundamental signal — it's an admission the standalone equity trade is over. Needham is the last one arguing upside above the deal, and that argument now has a closing date.
VERDICT: NOT THE SEXIEST NAME IN THE DIGEST, BUT THE QUARTER WAS CLEAN. GMV +14% organic ex-FX, 4% above guide and consensus. Focus categories +26%, now 40%+ of GMV for the first time. Street can't agree on the multiple: Argus upgraded to Buy at $133, BMO sits at $145 Outperform, while Susquehanna and Mizuho both hold Neutral at $110 — where the stock happens to trade. The debate is simple: execution is undeniable, active buyers are not.
Beat across the board. Revenue $3.10B vs $3.02B cons. EPS $1.60 vs $1.51. EBITDA $944M — 7% ahead of both firm and consensus. Take rate flat at 14%, gross margin 72%. That's pricing power.
U.S. GMV +24% organic. International +4%. That divergence is the bullish tell — this is U.S. execution, not e-commerce beta.
Focus categories accelerated to +26% from +24% in Q1 and crossed 40% of total GMV. Collectibles led with trading cards getting a World Cup/NBA Finals pop. Motors, fashion, refurbished also contributing. eBay Live grew 8x YoY. Management raised full-year guidance and Depop is the younger-buyer hook.
BULL: The marketplace is compounding where it matters. Focus categories are approaching half the business while growing 26%. The 72% GM funds the innovation cycle — they invest and still print margin. BMO's $145 PT says the re-rating has room.
BEAR: Active buyers flat QoQ. That's the bogey. GMV growth is coming from pricing per buyer and category mix, not new demand. Susquehanna's Neutral at $110 is basically "great print, no new money." InvestingPro's fair value flags the stock as overvalued at current levels.
Argus's Joseph Bonner makes the bull case in one block:
"eBay has outlined a strategy focused on driving growth through focus categories, high-value sellers, and enthusiast buyers. The company maintains a rapid pace of product innovation while preserving strong margins and cash flow."
That's the story. The counter is just as clean: at $110, with PTs clustered $110–$145, the stock sits at the floor — and flat buyers cap the multiple.
Stock at $110.14, up 28% over six months. Argus's upgrade adds fresh demand, BMO's $145 is the bull anchor, neutral PTs floor it at $110. r/r skews decent if focus categories keep compounding and Depop nudges the active buyer line in 2H. But this is a quality compounder, not a momentum melt-up — own it for the cash flow and the 72% gross margin, not for the multiple re-rating.
Evercore holding the line: OUTPERFORM, $350 PT after the MiTAC expanded partnership. Another islanded microgrid — this time Fremont's AI server manufacturing campus — stacking on top of the existing San Jose install. The deal itself is fine. The real tell is deeper.
FIRST TIME BLOOM QUANTIFIED ITS AI CUSTOMER BASE: NEARLY TWO DOZEN AI INFRASTRUCTURE CUSTOMERS. That's beyond the usual cited names (Oracle, Nebius, Brookfield, AEP, Equinix) and into the supporting layer — server/rack manufacturing, semis, testing. Same power-wall problem as data centers, same onsite answer.
Bull read: the entire AI supply chain just became Bloom's TAM, not just the compute itself. Bear read: customer count ≠ megawatts. No incremental MW disclosed here, so the revenue step-change is still a leap of faith.
The announcement highlights Bloom Energy's ability to address power needs for both AI compute and the supporting infrastructure layer, including server and rack manufacturing, semiconductors and testing facilities. — Evercore ISI
Not a needle-mover for the model. A needle-mover for the narrative — the franchise is spreading beyond the data center fence.
Rosenblatt holds the line at $220 Buy while the rest of the street grimaces at guidance. Q2 was a clean beat — RECORD $191.9M REV (vs $190.5M est), $0.06 EPS vs $0.02 — but Q3 guide came in 2% light on revenue and NINE CENTS below on EPS. That's the whole story: demand is fine, supply is the bottleneck. DSP and TIA shortages plus capacity delays cap near-term numbers.
The bull case lives in 2027, not the next two quarters. Rosenblatt cut CY26 on the constraints but raised CY27, applying a one-third discount to management's 2H27 data center revenue targets. At ~27x CY27 EPS, the $220 PT is a 2027 multiple, not a 2026 one. Needham trimmed to $190 but stays Buy — so the debate isn't direction, it's how long the supply chain chokes growth. Stock sits at $124.22 after a 456% year. Fifth straight record quarter, 86% YoY growth, and the market yawned. That's positioning recalibration, not thesis breakage.
"Rosenblatt considers its 2027 numbers potentially conservative."
The risk is obvious: management's 2H27 targets get discounted because they've missed capacity timelines before. The reward is equally obvious: if supply unlocks, those numbers aren't a ceiling — they're a floor.
GLJ flips VRT to Buy with a $381 PT — ~38% upside from $275.17. The call is channel-check driven: colos and neo-clouds are becoming as important as hyperscalers to the AI buildout, and VRT's end-to-end bundle makes it the default supplier. REVENUE UP 26% AND STOCK UP 98% IN A YEAR — momentum and narrative align.
Q2 was the usual mixed bag. EPS $1.52 beat by a dime, revenue $3.27B missed by $100M. Organic growth ~18%, FY guidance raised to the high end — so the miss is supply/timing, not demand rolling over. Bernstein trimmed PT to $368 from $416 on those supply concerns, UBS stayed Buy at $370.
"Our checks call out Vertiv as uniquely positioned to benefit from continuing acceleration as colocation providers and neo-clouds grow in importance to hyperscalers and frontier labs."
Net: the $236-$427 PT range tells you the Street is split on execution vs. tailwind. GLJ's upgrade is the freshest read — supply chain is the only thing standing between VRT and that $381 target.
UBS lifts U to $48 (from $32) but stays Neutral — and that's the whole trade in one sentence. The Vector AI ad acceleration is real and Q2 proved it. But the stock's up 28.7% in a WEEK. The easy money's been made.
Q2 was a clean beat: EPS -$0.05 vs -$0.11 consensus, revenue $546M vs $514.62M. The driver: Vector's runtime data got integrated into the ad platform in June — earlier than expected — and growth accelerated to 23% QoQ. Annual run rate just crossed $1B. That's why UBS raised 2027/2028 revenue estimates +21%/+19% and Adjusted EBITDA +55%/+42% (Supersonic sunset is doing wonders for mix).
This isn't a fundamentals question anymore. It's a positioning question. UBS says the catalyst is now "reflected in estimates" — and they'd rather own APP and LFTO for exposure to larger, faster-growing non-gaming ad budgets. That's a fair point. U at $40.81 after a 62.5% six-month run is pricing in a lot of Vector success. BofA (Buy, $50) and Macquarie (Outperform, $50) are more constructive, but they're also chasing the same Vector thesis.
"With the main catalyst now reflected in estimates, attention may shift to AI disintermediation risk on the gaming engine side and potential disruption as Unity transitions game creators to the upgraded Unity 7 engine in 2027."
That's the sleeper risk. Ad growth is the headline. But the engine business — the thing that makes Unity Unity — faces AI disruption pressure, and the Unity 7 migration in 2027 is a real execution overhang. PMs should be asking: how much of the $1T AI ad narrative is already in this price?
Verdict: Vector is a legit re-rating story, but UBS's Neutral at $48 with better r/r elsewhere is the honest take. If you're long from the 20s, trim into strength. If you're flat, wait for the post-earnings fade. Don't chase the green.
BofA raised their PT to $30 and the stock still trades at $34.54 — 15% ABOVE the new target. That's the whole setup in one line: the bear keeps moving the bogey, and the tape keeps running past it.
Funk's math: 9x 2027 P/FCF (from 8x) on better paying-user growth, still Underperform, still below the 13x multiple low-growth software peers command. The bull side has the momentum though. Q2 printed clean — EPS $0.75 vs $0.74 est, revenue $631.5M vs $626.7M — and William Blair finally capitulated, upgrading from Underperform to Market Perform.
Blair's call: increasing confidence in reacceleration of the core FSS business under new leadership — citing paying-user growth, Teams trends, and customer lifecycle metrics.
Stock still faded after-hours because revenue growth remains sluggish. But near the 52-week high with a double-digit FCF yield supporting the floor, the market's clearly buying the reacceleration story. BofA is the last credible bear standing, and their target is already in the rearview.
Cloudflare just served its best quarter since 2021 and the tape responded accordingly — 16% AH pop, PTs flying to $350-355. REVENUE +36%, a 5% beat, with growth ACCELERATING 2 POINTS SEQUENTIALLY. First sequential gross margin improvement in 10 quarters (73%, still down materially YoY). Management raised FY26 guidance to 32% — 2 points above consensus. This is a reacceleration story, not just a beat-and-raise.
UBS went $250 → $350 but stayed Neutral, and that's the whole philosophical divide in one call:
"With the stock trading at 33x CY27 revenue after the 16% AH move, we remain Neutral."
The fundamentals aren't the debate. cRPO +35% (TD Cowen), largest revenue beat in 18 quarters (Jefferies), record net new customer adds (Barclays), plus go-to-market momentum and the Act 4 opportunity. But the stock ran 64% in six months into this print — the market already believed.
Bulls frame reacceleration + Act 4 as the base case, not the peak. Bears look at 33x forward revenue for a 32% grower with gross margin still compressing YoY and call it priced for perfection. Both are coherent. UBS is the tiebreaker vote, and they're telling you the multiple is the whole ballgame.
Needham to $300 from $260 (Buy). Macquarie to $260 from $230 (Outperform). The bull case here is NOT the AI headline number — it's that the base business is accelerating WITHOUT AI. Non-AI customers grew high-20s YoY, AI customers are diversifying in both count and scale, and the $1.121B print (+36% YoY, accelerating from 32%) marks the FIFTH straight quarter of revenue acceleration. That's a rate-of-change story, not a one-off beat.
The bear angle: the largest AI customer reduced usage in Q3, and management de-risked 2026 guidance by trimming revenue assumptions on that customer down to the minimum commitment. But here's the twist — that same customer signed a NINE-FIGURE renewal for 17 products in Q3 2026. So the "reduction" is usage intensity, not relationship. That reads like digestion, not churn.
"Needham views the acceleration of the non-AI business and growing breadth and scale of AI customers as supportive of secular trends and Datadog's durable growth."
NRR held at low-120s. Gross margin 79.5%. At $81.6B market cap and 538x P/E, the multiple prices in perfection — but the acceleration curve is doing what the multiple needs it to do. Watch whether the "largest customer de-risking" becomes a pattern or stays a one-off. If non-AI keeps accelerating, this thing compounds. If AI usage wobbles again, that P/E is a liability.
Rosenblatt nudges PT to $32 from $29. Big deal — stock trades at $30.21, 66% higher in six months. The Q2 print earned it, barely.
REVENUE $312M, +10% YOY, ABOVE THE HIGH END. SUBSCRIPTION +14% — third straight quarter of acceleration. AI REVENUE +78% TO ~$39M. Momentum is real.
The headline: LARGEST NEW-LOGO WIN EVER. Fortune 100 financial services, ~$100M TCV over five years, closed with Google and a global SI via GCP Marketplace. Google distribution is the bull case — this is proof of concept.
"The deal was won jointly with Google and a global systems integrator and transacted through Google Cloud Marketplace."
The bear case lives in FCF, not revenue. Q2 PRINT: $15M, 5% MARGIN — MISSED STREET'S $28M. Rosenblatt blames seasonality, annual billing, and data center refresh capex. Maybe. But at a 24% EBITDA margin guide, PMs will want cash conversion to follow.
FY26 REVENUE MIDPOINT UP TO $1.266B. EPS held at $3.22-$3.30. FCF REAFFIRMED AT ~$175M. Yet the stock dropped post-print on margin pressure and a cautious profit outlook. That tells you the bar was high and the market's not fully converted.
The Uber delinkage just torpedoed the growth narrative. Oppenheimer sliced the PT to $7 from $20 — stock sits at $5.68 — and kept Outperform. That's not a conviction call on the base case; that's a balance-sheet-and-optionality rating.
The firm slashed revenue estimates and rebuilt bot capex to reflect a delivery ramp without Uber's scale behind it. DoorDash deliveries tracking okay, but Oppenheimer is blunt: onboarding new platforms takes time because bot workflows and human driver workflows are structurally different. They see a potential Uber reunion but refuse to model one. (Smart. Trust but verify got burned.)
"Integration on new platforms takes time as work flows for bots and human drivers differ significantly."
The quarter tells the same story. Q2 REVENUE $3.2M (+400% YOY, +9% QOQ) but a $0.59 non-GAAP loss, a sharp FY guide cut, and the FIRST-EVER QUARTERLY DECLINE in Uber-linked delivery volume. After-hours: -11%. The engine is sputtering.
The bull case rests on autonomy progress — Oppenheimer credits real technology advancement. The bear case is the math: slower ramp plus dilution. The $7 PT bakes in both. At $5.68, you're buying a call option on Serve rebuilding delivery momentum before the cash burn forces another dilutive raise. That's the whole r/r in one sentence.
Deal arb, not a stock. Nielsen takes DV out for $13.50/sh cash — $2.1B, 30% premium to the 60-day VWAP. Stock sits at $11.71, still ~15% below the offer. That's the entire bull case now: collect the spread until close.
Needham cut to Hold, PT suspended. So did the rest of the Street — RBC, Canaccord, Raymond James, Truist, BMO all downgraded, PTs marked to $13.60 (from a $14-16 cluster). No price discovery left. Just deal math.
"This transaction represents a fair price for DoubleVerify given its slowing revenue growth." — Needham's Laura Martin
Fair is the right word. DV prints an 82% gross margin, but growth is decelerating and the equity's been struggling. Nielsen gets a scaled ad-verification franchise at a discount to its historical multiple. Smart buy for them.
No competing bidders coming — Providence (12% stake) already pledged yes. Earnings call cancelled. The only real question is why the spread is still 15% on a cash deal with the anchor holder locked. If you trust the close, that's your carry. I lean toward it tightening.
Inflection confirmed. PUBM just printed Q2 with REVENUE $78.6M VS $69M BOGEY and EPS $0.12 vs the -$0.23 loss expected — double-digit growth came a quarter early. Stock's already up 108% in six months, near the 52-week high of $14.04, and the sell-side is scrambling to catch up: Rosenblatt to $23 (from $21), Raymond James upgraded to Outperform with $22, B.Riley to $17.
Growth is broad-based — agentic AI, mid-tier SSP expansion, mobile, audio — and it's offsetting the DSP partner reset that was the overhang. Management says 2H accelerates. Core valuation isn't greedy: ~7x 2026 EV/EBITDA against a low-20% CAGR. (Rosenblatt also slaps $10 of the $23 target on ad tech antitrust remedies — lottery ticket optionality, not the base case.)
"Rosenblatt said this multiple represents a discount to what it now estimates as a compound annual growth rate in the low 20% range for the company."
Risk is the DSP reset lingering, but Q2 says it's done. Watch the Q3 guide — if they raise, the re-rating has legs.
UBS keeps the Buy but trims the PT to $120 from $130 — the cut says more about the setup than the quarter. MCHP just smashed the high end of guidance, raised the outlook ~8% QoQ at the midpoint, and printed GM running ahead of its 65% model. Yet shares sit at $74.36. That's the market pricing the inventory build, not the momentum.
ADJ EPS $0.76 vs $0.70 est, REV $1.48B vs $1.46B est — +13.2% QoQ, +38% YoY. Non-GAAP GM 63.8%, OM 35.1%. Data center is now ~17% of revenue, the HIGHEST among major peers, with production starting on PCIe Gen 6. Management raised guidance across sales, margins, and profit. Hard to spin that as anything but one of the strongest quarters in recent years.
UBS still trimmed CY28 revenue and EPS — $5.95 for 2028, $4.93 for 2027 — on "a more moderated view on how long the company can remain above seasonal trends." The gives:
"Both distributors and direct buyers appear to be building inventory due to shortage concerns."
That's the textbook double-order tell in semis. The bull case: the guides keep going up and DC mix is best-in-class. The bear case: if that inventory is pull-forward demand, the air pocket lands in CY27/CY28 — precisely where UBS just cut.
Valuation math: $120 = 20x CY28 EPS. That's ~61% implied upside from the current tape, which is effectively saying the market doesn't trust the durability yet. If the inventory clears without a demand air pocket, this re-rates hard. If it doesn't, $74 starts to look generous. Watching the next guide.
Block's the rare name where the narrative flipped from "growth at any cost" to "growth WITH discipline" — and the tape's paying up for it. Argus raised PT to $103 from $85 (Buy maintained), but that's just one of five bullish calls in the last few days: UBS $98, Needham $100, Cantor $95, Mizuho $100. BMO lags at $85. The cluster's $85-103, all Buy or Outperform.
Q2 was the proof point. Adjusted EPS $1.02 vs. $0.87 consensus, GROSS PAYMENT VOLUME +12% Y/Y — accelerating from Q1's 11% — with food & beverage up 20%. Management raised FY26 guidance on gross profit, operating income, and EPS. The 40% headcount reduction from February is doing exactly what it was supposed to do.
The bull case: growth survived the cost purge. Square and Cash App ecosystems still driving adjusted gross profit, and the new Neighborhoods loyalty program has early traction with Cash App users. BMO's the holdout — they want to see growth carry without leaning on the cuts.
The bear case is valuation, plain and simple. P/E of 144. Stock already +41% over six months. Argus's $103 implies 20x their 2027 EPS — you're paying for perfection. But with guidance raised and volumes accelerating, nobody's pressing that short right now.
BMO hosts GEV IR for Texas investor meetings post-Q2, walks away sticking to Outperform / $1,250 PT. Stock at $1,000.30 — that's a clean 25% bogey, and the street's skewing higher, not lower.
The collective analyst narrative is one story: GAS TURBINE DEMAND IS SUSTAINED, services revenue accelerates, and data center electrification powers a multi-year capex supercycle. Guggenheim raised to $1,450, Jefferies at $1,210, and Mizuho even bumped their Neutral to $949 — when the skeptic is chasing the tape, that tells you something.
BMO updated its Gas Power Mini Model on the company's latest capacity expansion plans. That's the supply-side tell: if the bottleneck to AI power is turbines, GEV just told the street it can build more of them.
"We came away incrementally constructive on the company's long-term earnings power." — BMO's Ameet Thakkar
Polite sell-side for "the numbers are going up." The bear case is valuation — shares already +55% in a year — but with the lone Neutral below the price and still raising, the r/r is obvious.
UBS slaps a $804 PT on CACI (from $598), keeps Buy — and this isn't just quarter-chasing. The print was clean (EPS $8.91 vs $7.32 est, rev $2.71B vs $2.70B), but the real signal is FY27 guidance: 7.2% organic growth at the midpoint, matching two straight years of 7.2% delivery. Consistency at that rate, with margins expanding 150bps and organic funded backlog +19%, is the kind of compounder the market underpriced.
The flywheel is AI-led. Customers are taking CACI's productivity gains and reinvesting the savings back into more CACI work — that's a self-funding demand story, not a one-quarter tailwind. ARKA revenue synergies are materializing, and management is staffing up with multiple executive hires to push it further.
"CACI stated that its deployment of AI for productivity gains has led customers to spend those savings on additional CACI offerings."
Valuation still isn't stretched: 13.5x / 12.3x FY27 / FY28 EBITDA, roughly in line with the stock's 10-year average discount to the S&P 500. UBS flags light positioning for the >20% rip off the print — fair, though the $206 PT hike says the desk believes the guide, not just the squeeze. Backlog at $32B+ and FCF up 68% to $735M gives the balance sheet room to keep buying growth. Good setup, still not the crowded trade.
Needham keeps the Buy and $90 PT. Defense is the story; China-sourced optics are the bogey. Stock's up 268% in a year — this is a crowded momentum name that just took a step back on guidance.
The quarter itself was clean: REVENUE +34% YOY (consensus 27%), EPS $0.15 vs $0.14 est, EBITDA at upper end of guide. Aerospace & defense revenue +41%, with A&D product revenue +72%. That's the JLWS-driven inflection playing out exactly as the bull case promised.
Then guidance got messy. Q3 midpoint sits slightly below consensus, and supply chain constraints on China-sourced optical components defer ~$17M of product revenue. Needham trimmed 2H26 and 2027 estimates on commercial uncertainty — but left defense intact.
"The aerospace and defense business appears unaffected by the supply chain issues."
That's the whole ballgame. If defense carries the story, the commercial deferrals are timing, not destruction. If those components stay tight, the market keeps discounting the non-defense piece. The $90 PT implies decent upside from $75.44, but this stock doesn't move on PTs — it moves on quarterly defense prints and JLWS update cadence. Watch that next quarter more than the guide.
The take: Wedbush thinks Lumilens' $700M raise and hyperscale customer win is a green light for POET's story — and the tape agrees, +22% on the week. The chain is simple: Lumilens just secured a $5.51B valuation and a multi-billion dollar contract with one of the big four US hyperscalers, which makes their $50M PO to POET for EOI engines look a whole lot more credible. But we're still talking about a $1.47B market cap on $503K of quarterly revenue — you're paying for narrative, not earnings.
This is a validation moment for the optical packaging thesis. Lumilens exited stealth with real money and a real customer, and Wedbush sees the read-through as straightforwardly positive: a properly funded downstream customer de-risks POET's design-win pipeline. The market is voting with its feet — POET up 45% over six months, now at $8.53.
Wedbush: "The Lumilens funding announcement and hyperscale customer win will likely be seen as favorable for POET Technologies."
Night Market Research is short and alleging POET overstated partnerships — specifically that the Celestial AI relationship may have ended years ago despite recent disclosures. That's a credibility hit on top of a horrid Q1 print (revenue $503K vs. $2.2M consensus), and the $400M registered direct offering they sold at $21 per share doesn't square with the $8.53 tape — so dilution math is doing heavy lifting. Momentum is real, but so is the volatility. Not sure we can read too much into one funding round when the short thesis is about disclosure quality, not customer wins.
Jefferies flips to Buy from Hold, PT to $50 from $35 (stock $31.62 — yes, it's already up 240% in a year, but the new target says the run isn't done). The old Hold was never a business quality call. It was a profitability timing question: when does non-GAAP breakeven start and does it stick? Q2 gave Jefferies the answer.
REVENUE $24.1M BEAT ($22.0M est) and the EPS miss (-$0.10 vs -$0.06) is noise against the operating prints: ACV + royalties $99.5M RECORD (+44% YoY), RPO $135M ALL-TIME HIGH, TTM royalties +65% to $8.6M. With 88% gross margins, the Q4 2026 profitability call isn't heroic. It's arithmetic.
Growth story broadening too. AI licensing (hyperscalers, ASICs, chiplets) was the 2025 trade. Now security via Cycuity plus the expanding Arm relationship is another incremental engine on top of the ~20% licensing CAGR base. The kicker: MORE THAN 60% OF DESIGN WINS STILL AREN'T PAYING ROYALTIES. That's the 2028 acceleration story.
"We see the high-30s-to-low-40s percent royalty CAGR as conservative given the automotive-AI combination."
Jefferies sees a path to $1.50+ EPS on a $250M 2030 revenue target. At $31.62 that math works. The caveat — this is validation, not discovery. The easy money on the 240% move is made. But the first major buy rating with a credible profitability timeline flips the risk/reward for PMs who missed the first leg.
MU — Citi's downgrade is a momentum killer, not a thesis killer. The DRAM QoQ deceleration path (23% → 9% → 2% → 0%) plus CXMT/YMTC 2H27 capacity is a real supply overhang, but Adata/Winbond pushing back on 3Q26 pricing tells you the near-term deck isn't rolling over. This is a momentum-to-GARP transition requiring shareholder base turnover. The LTAs into 2029-2030 are either enforceable contracts or worthless paper — that's the whole debate.
VST — Revenue miss, EBITDA beat. The market should focus on EBITDA quality, and the +31% YoY adjusted EBITDA on a revenue decline says repricing power is real. The equipment cost doubling/tripling story is the moat — customers pay a premium for existing dispatchable generation because new build is uneconomic. 22 buys, 0 sells means you're late if you're not in.
CEG — VST's call is a direct bid for nuclear. High availability, low variable costs, existing interconnections, carbon-free attributes — that's the scarcity combo. FERC's co-location clarity removes the regulatory overhang. This is the cleanest structural repricing in the power complex.
TLN — The PJM orientation is the edge. Nuclear sites with existing interconnection are the scarce asset class, and PJM's proposed large-load procedures make behind-the-meter co-location the path of least resistance. Top read-through from VST's commentary.
NRG — Secondary beneficiary. Gas generation sites and retail relationships are real assets, but you're not getting nuclear scarcity premium. Lower beta to the nuclear repricing trade. Fine to own, not the pure play.
FLNC — Direct negative. Battery returns at ~20% of original expectations kills the merchant storage underwriting model. Falling spreads plus higher cost of capital plus queue slowdowns — triple whammy. Avoid.
ACMR — THE advanced packaging print. Revenue $292.9M vs $269.3M est, ECP +168% YoY, advanced packaging +153%. This is the capex cycle inflecting, not a one-quarter beat. FY26 guide roughly in line means the market should pay up for the growth vector.
NVDA — $225 into 8/26 earnings with SpaceX anchoring 10GW by 2027? That's a gift if you trust the build. The Rubin Ultra 8-Hi HBM testing is a content-per-GPU negative but potentially a unit-volume positive. Memory scarcity is forcing architectural tradeoffs — that's bullish for NVDA's pricing power.
GOOGL — The model layer is lost. Gemini behind frontier, Anthropic out-executing on cadence and talent, Search (60% of profits) facing structural disruption. The cloud revenue / TPU rental strategy monetizes compute but concedes the AI layer. At 27x forward PE, the risk/reward is imbalanced. Market treats it as defensive; it's not.
SHOP — Agentic search flips the marketplace model. Agents optimize for relevance, not ad spend — that breaks marketplace dominance and favors the long-tail catalog. Shopify's product catalog becomes the retrieval infrastructure for AI commerce. More defensible than storefront software.
ABNB — The cleanest AI earn in consumer internet. Q2 beat, +15%, and Chesky credits AI pricing/search tools as the single biggest growth lever. AI investment without headcount growth is the operating leverage story.
AMZN — CPU capacity crunch is an AI-driven demand signal. Engineers facing multi-day CPU server waits means the broader compute pool is stressed, not just GPU. AWS capacity constraints are a feature, not a bug — pricing power follows.
MSFT — +42% in a month. $3T. The SpaceX report flags Microsoft as potentially the largest off-taker for 10GW — that's pricing a second AI infrastructure supercycle. Vineland petition risk is a hiccup, not a thesis-breaker.
TSLA — Driving solved; mission delivery is the last mile. TeraFab building AI inference processors for Optimus/Cybercab vertically integrated — that's the long-dated autonomy margin story. Not a near-term catalyst.
INTC — THE most interesting setup in semis. TeraFab on 14A = 15% royalty on logic wafer value. At scale, that's a 100% GM annuity no one has modeled. Ibiden's Gama plant timing de-risks the 2028 EMIB-T ramp. Cheapest way to play TeraFab revenue.
TXN — Internal fabs and inventory position for the auto/industrial recovery. When the cycle peaks, there will be a fight for capacity and TI has the structural cost advantage. Cycle positioning, not catalyst.
WDC / SNDK — 256TB-class SSD removing $300K of DRAM per server is a substitution risk the market hasn't priced. SNDK's $15B buyback is management telling you the cycle isn't peaking. Memory peaked narrative is pod de-grossing, not cycle top.
ALAB — Scale-up networking in a memory-constrained world. The switch franchise intersects with optics right as scale-up demand tightens. Earnings call helps triangulate Scorpio X pricing.
GFS — Early mapping of non-CMOS optic controllers. Mentioned in the first five minutes of the podcast — that's positioning, not confirmation.
LITE — Grouped with NVDA/MU/SNDK as AI value-chain beneficiary. No specific data point, but the grouping signals demand-side read-through. Optics remains tight.
FN / COHR — AAOI's beat lifts the module assembly complex. AAOI sold out through Q2 2027 validates the 1.6T cycle. Coherent has InP and laser capacity — that's pricing power in a scarce-input market.
MCRY — Turnaround is genuine but the re-rating to premium compounder multiples raises the execution bar. Accelerated revenue recognition can pull forward demand. Watch backlog-to-cash conversion.
CW — Nuclear optionality is the premium driver. Naval nuclear propulsion and reactor I&C create switching costs. But the premium multiple prices timely backlog conversion — and nuclear timelines are never timely.
ONTO — Q2 revenue +35.3% YoY, GM expansion to 53.4%, orders >$1.1B with 60-70% landing in 2026. Advanced packaging growth revised from 50% to 80%. Second major pull-in phase after foundries. Fundamentals unambiguous, multiples be damned.
AMAT / LRCX — Smashed quarters, price action says otherwise. That's multiple compression despite accelerating fundamentals. LRCX especially — the market wants price leadership before paying up for 2027 numbers. MKSI is the less crowded way to play the same cycle.
ASML — TeraFab at 50x the Pentagon's size means massive litho/etch/dep/metrology/inspection demand. Both leading-edge and mature tools. The leverage point for the build-out.
TSM — MoS2 top-gate breakthrough potentially enabling 0.7nm extends the roadmap. DRAM shortage jamming Apple packaging confirms memory is now a packaging-bottleneck input. Pricing power for memory, schedule risk for TSM.
AMD — Split field, not zero customers. Anthropic committed up to 2GW of MI450 is a real multiyear deal. But SpaceX exclusivity for NVDA plus Helios slip to Q1 2027 hurts the narrative. The Taalas acquisition (hardcoding weights into logic) is strategic optionality. Shanghai-based AI engineering team is an underpriced geopolitical risk.
MRVL — Structera A with SK hynix turns memory into an active compute element — aligns with the CPU bottleneck thesis. AAOI's 1.6T ramp benefits DSP/laser content over module assemblers.
AVGO / MTSI — Optical component scarcity in the 1.6T ramp gives pricing power to DSP, laser, and TIA vendors. AAOI's beat validates the stack, but the margin profile lives higher up the chain.
KVYO / HUBS / FIG — The SaaS AI monetization divide. HubSpot seeing AI cannibalize budgets is a warning. Klaviyo's Composer usage not showing in revenue is the gap. Figment is the rare AI-driven usage actually hitting the income statement while maintaining margin guidance.
DASH — LTM EBITDA per order at 49 cents vs 3 cents two years ago. That's the operating leverage story. Unit economics this durable re-rates the earnings power.
PLTR — Value-based pricing in software is the moat. Burry's puts are flow, not fundamental. Big weekly gains on AI monetization conviction.
BABA — Qwen weights open but not free — paid licenses and revenue share for large commercial users. Model licensing becomes a revenue line. Monishot's Kimi K3 seeking 30% rev share validates the model-as-a-service monetization path in China.
NBIS / CRWV — SpaceX entering the neocloud market is a structural repricing. D.A. Davidson cutting NBIS PT from $250 to $175 on Vineland uncertainty plus 2,900 petition signatures — double derating: regulatory and competitive. CoreWeave's contracted backlog is the only defense against a well-capitalized, vertically integrated competitor.
GEN — The AI left-tail hedge. AI-driven cyber attacks force security spend. Raised full-year guidance citing AI/agentic concerns as core driver. Market underpricing the safety-regulation angle.
AKAM — Beat and sold off. CDN displacement by AI-native edge. The market is selling anything without an AI pivot to fund winners.
JPM — $500B tech bond issuance forecast. Credit-fueled capex cycle with hungry long-duration buyers. If rates rise, the whole flywheel faces refinancing risk. Watch CDS, not just EPS.
AAPL — DRAM shortage jamming packaging at TSMC. Supply bottleneck outside Apple's control. Memory allocation favors high-margin AI users over consumer electronics. Shipment timing risk.
META — MTIA cut to 200K units in 2026 but ~900K in 2027 with new generation every 6 months. Custom silicon pivot is real. Renting TPUs from Google undercuts full-stack AI independence narrative — it's a short-term capacity fix, not a moat.
SKHY — ~$38.3B investment through 2031. That's the strongest signal of cycle durability. Google DeepMind publicly endorsing HBF validates the roadmap. Citi raising estimates vs Citi downgrading MU — the split is Chinese supply timing vs structural demand.
WOLF / ON / IFNNY — SiC expanding beyond EVs into AI power delivery. Wolfspeed's 800VDC partnership with LITEON for hyperscale is a demand validator. Infineon formalizing humanoid motor control as a named target segment. Incremental, but the TAM direction is right.
TSEM — BofA initiates Buy with PT $367 vs ~$225. Tower is the leader in AI datacenter SiPho PIC manufacturing with revenue expected to double in 2026. 1.6T SiPho PIC has the clearest demand visibility and dominant share.
OKLO — Criticality in less than a year after groundbreaking. SMR progress validating. Focus shifts to licensing and first commercial plant.
CTSH — Claude Code replacing Copilot for COBOL migrations — 30-35% developer effectiveness gain. Enterprise IT services as AI deployment channel. Validates Anthropic's value chain climb.
SAP — Freezing travel because of AI costs. AI spend hitting P&L budgets at enterprise software companies. Watch if this spreads.
Hearing the VST call had PMs re-underwriting FLNC positions into the close. The battery returns comment (~20% of original expectations) is getting flagged as a sector-level warning, not just a VST-specific observation.
Word is GM and xAI have held early discussions about securing dedicated power supply from the TeraFab build — nothing signed, but the BYOP (bring your own power) model is becoming the template for hyperscale AI.
Channel checks suggest Adata and Winbond are offering LTAs into 2029-2030 with penalty clauses — the question is whether memory customers sign those knowing Chinese supply hits in 2H27. Some procurement teams are reportedly refusing multi-year commitments at current prices.
Hearing Nvidia's Rubin Ultra testing with 8-Hi HBM is causing some large-model customers to pre-order additional GPU quantities to compensate for reduced per-GPU memory. That's a unit-volume offset to the content-per-GPU reduction.
Word on the street is Anthropic's Astra model is genuinely impressive on agentic coding but the cyber capability findings are real — one AI safety person called it "the first model that made the safety team nervous about release."
Channel checks suggest Google's TPU rental to Meta was structured as a capacity swap, not just a compute purchase — Google gets first look at Meta's software stack in exchange for silicon. Interesting strategic angle the market hasn't caught.
Hearing Groq's SRAM LPX integration with Nvidia involved more than the $20B — the strategic piece is Nvidia hedging HBM dependence with an alternative memory path. Multiple sources confirm the deal but dispute whether it's $20B or closer to $15B.
Word is the DeepSeek hedge fund's July losses are causing broader de-risking in China AI names — not a fundamental read on the models, but the interconnect between the lab and the fund is a unique risk channel.
Channel checks suggest the Texas data center pause could hit ~20% of the US pipeline — and one large developer is already re-routing new capacity to Oklahoma and Arizona. The audit itself is the risk; no one knows the timeline.
Hearing SK hynix's $38.3B commitment includes a significant portion for HBF — not just HBM. DeepMind's public endorsement was the green light for full-scale production investment.
Whispers on the AMD Shanghai AI engineering concentration — top MI-series architects are mainland China-based, and export control tightening would hit development velocity directly. This is not in anyone's model.
Word is the CSP (Cloud Service Provider) CPU wait times at AWS have CIOs reconsidering on-prem GPU/CPU clusters — one large enterprise reportedly expedited a Coloverse order after a 5-day wait for CPU capacity.
Hearing Oracle's distributed cloud is getting pulled into the power conversation — the TeraFab model (own the power, own the compute) is making hyperscaler capex plans look underfunded for the same capacity.